TABLE 2.

Changes in clinical measures by texting enrollment

	Control (n = 186)			Texting Intervention (n = 185)
				12‐Week program (n = 91)			20‐Week program (n = 94)
Variable	Baseline	Final	p	Baseline	Final	p	Baseline	Final	p	p‐value between groups
Body weight, kg	114 (27)	112 (26)	<0.001*	114 (29)	113 (29)	0.22	111 (28)	109 (28)	0.002*	0.25
Weight loss, kg		−1.9 (9.1)	<0.001*		−0.7 (4.9)	0.22		−1.5 (4.9)	0.002	0.25
Weight loss, %		−1.2 (4.3)	<0.001*		−0.6 (3.8)	0.13		−1.1 (4.7)	0.003*	0.30
HbA1c, %	6.8 (1.7)	6.7 (1.6)	<0.001*	6.8 (1.5)	6.7 (1.4)	0.26	6.6 (1.8)	6.3 (1.4)	0.007*	0.16
Cholesterol, mg/dL	186 (53)	179 (44)	0.17	178 (44)	179 (47)	0.97	183 (420	178 (38)	0.15	0.54
HDL, mg/dL	46 (11)	46 (12)	0.99	50 (13)	48 (12)	0.12	50 (14)	50 (13)	0.78	0.36
LDL, mg/dL	109 (49)	104 (37)	0.36	105 (49)	103 (51)	0.37	115 (63)	105 (44)	0.24	0.83
Non‐HDL, mg/dL	140 (54)	134 (40)	0.28	124 (43)	124 (48)	0.80	132 (38)	129 (38)	0.30	0.65
Triglycerides, mg/dL	152 (98)	147 (86)	0.29	152 (103)	153 (113)	0.35	151 (170)	134 (90)	0.89	0.93

Note: p‐values for within group comparisons were calculated using the Wilcoxon signed‐rank test. p‐values for the between group comparisons used the Wilcoxon rank‐sum test.

Abbreviations: HbA1c = hemoglobin A1c; HDL = high‐density lipoprotein, LDL = low‐density lipoprotein, Non‐HDL= Non‐high‐density lipoprotein.

^* Difference within group was significant p < 0.01.